Oxford Immunotec: Oxford Immunotec and QIAGEN N.V. Settle Patent Infringement Lawsuit

Agreement includes payment of $27.5 million to Oxford, royalty-free license to QIAGEN and dismissal of all pending litigation OXFORD, United Kingdom and MARLBOROUGH, Mass., Dec. 15, 2017 (GLOBE NE...